Maha S. Sidhom

Impact of the <i>CYP2C8</i> *<i>3</i> polymorphism on the drug–drug interaction between gemfibrozil and pioglitazone

Christina L. Aquilante, Lisa A. Kosmiski, David W. A. Bourne et al. · British Journal of Clinical Pharmacology · 2012 · 57 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease

Anh Vu, Maha S. Sidhom, Brooke C. Bredbeck et al. · Diabetology & Metabolic Syndrome · 2014 · 38 citations · Full text

Veterinary Medicine, Endocrinology, Diabetology +15

Influence of<i>SLCO1B1</i>Polymorphisms on the Drug‐Drug Interaction Between Darunavir/Ritonavir and Pravastatin

Christina L. Aquilante, Jennifer J. Kiser, Peter L. Anderson et al. · The Journal of Clinical Pharmacology · 2011 · 25 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Influence of <i><scp>CYP</scp>2<scp>C</scp>8*2</i> on the Pharmacokinetics of Pioglitazone in Healthy African‐American Volunteers

Christina L. Aquilante, Michael F. Wempe, Samantha Spencer et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2013 · 20 citations

Medicine, Pharmacokinetics, Pharmacology +13

Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers

Christina L. Aquilante, Michael F. Wempe, Maha S. Sidhom et al. · European Journal of Clinical Pharmacology · 2013 · 13 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +15